Janux Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JANX and other ETFs, options, and stocks.About JANX
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.
JANX Key Statistics
Stock Snapshot
Janux Therapeutics(JANX) stock is priced at $15.74, giving the company a market capitalization of 959.59M. It carries a P/E multiple of -8.77.
As of 2026-07-08, Janux Therapeutics(JANX) stock has fluctuated between $15.70 and $16.20. The current price stands at $15.74, placing the stock +0.2% above today's low and -2.9% off the high.
The Janux Therapeutics(JANX)'s current trading volume is 151.63K, compared to an average daily volume of 1.99M.
In the last year, Janux Therapeutics(JANX) shares hit a 52-week high of $35.34 and a 52-week low of $12.12.
In the last year, Janux Therapeutics(JANX) shares hit a 52-week high of $35.34 and a 52-week low of $12.12.
Analyst ratings
83%
of 18 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.